Saturday, February 20, 2016

At last, Sequenom Decided

The Sequenom case has finally been decided  by the federal appeals court.  The court struck down the patent for a Down Syndrome Test.

We first reported on the case back in January of 2013.

Our most recent update was in June of 2014.

You can read a detailed analysis of the decision on the PharmaPatents blog  here.

We predict that the case will be appealed to the US Supreme Court and the SCOTUS will deny cert.